Ribonucleic Acid (RNA) Development Platform
The Government is investing $69.5 million excluding GST over 7 years in a Strategic Science Investment Fund (SSIF) Platform for Ribonucleic Acid (RNA) development. This is to ensure New Zealand has well-connected and world-class research capability to strengthen the use and commercialisation of RNA technology.
Te Herenga Waka – Victoria University of Wellington and Waipapa Taumata Rau – the University of Auckland are partnering to develop and co-host an approved RNA Development Platform, with support from the Te Whare Wānanga o Ōtākou – the University of Otago and the Malaghan Institute of Medical Research.
Below is the public statement.
Read the public statement
Ribonucleic Acid (RNA) Development Platform(external link) — Victoria University of Wellington